4 months ago
KYMR
AnalystsKalpit PatelKalpit Patel's Stock Forecasts
AnalystsKalpit Patel
Sectors:
Analyst Ranking
Top 27%
#1473 out of 5548 analysts
Average Return
+3.7%
Win Rate
48%31 out of 65
Risk vs Reward
Poor
Good
Kalpit Patel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +209.09% | $19.09 | $58.99 | 2024-06-11 - 2024-10-14 | Strong Buy |
Journey Medical CorpDERM | +186.29% | $1.24 | $3.55 | 2023-05-23 - 2024-05-22 | Strong Buy |
Journey Medical CorpDERM | +174.40% | $2.07 | $5.68 | 2023-07-12 - 2024-07-11 | Strong Buy |
Revolution Medicines IncRVMD | +164.93% | $70.58 | $186.99 | 2025-11-18 - 2026-10-23 | Buy |
Journey Medical CorpDERM | +160.62% | $1.41 | $3.68 | 2023-03-30 - 2024-03-28 | Strong Buy |
Kalpit Patel Analyst Color
Get additional color on Kalpit Patel's coverage of popular stocks
2 years ago
RIGL
2 years ago
LBPH
Kalpit Patel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arrivent Biopharma IncAVBP | 3 | Strong Buy | $29.00 | +38.10% | Maintains | 5 days ago |
Taysha Gene Therapies IncTSHA | 1 | Buy | N/A | N/A | Initiates Coverage On | a month ago |
Verastem IncVSTM | 5 | Buy | N/A | N/A | Initiates Coverage On | a month ago |
Zymeworks IncZYME | 1 | Buy | N/A | N/A | Initiates Coverage On | a month ago |
Janux Therapeutics IncJANX | 2 | Buy | $23.00 | +38.06% | Upgrades | 2 months ago |
Corcept Therapeutics IncCORT | 3 | Sell | $50.00 | -41.77% | Downgrades | 3 months ago |
Kymera Therapeutics IncKYMR | 7 | Strong Buy | $155.00 | +39.94% | Maintains | 4 months ago |
Tyra Biosciences IncTYRA | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 months ago |
Cg Oncology IncCGON | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 months ago |
Mirum Pharmaceuticals IncMIRM | 1 | Buy | $145.00 | +80.37% | Initiates Coverage On | 5 months ago |
Soleno Therapeutics IncSLNO | 2 | Hold | N/A | N/A | Downgrades | 7 months ago |
Genmab AGMAB | 1 | Buy | $32.00 | -26.92% | Initiates Coverage On | 7 months ago |
Olema Pharmaceuticals IncOLMA | 1 | Hold | N/A | N/A | Initiates Coverage On | 7 months ago |
Krystal Biotech IncKRYS | 1 | Hold | N/A | N/A | Initiates Coverage On | 7 months ago |
Beone Medicines LtdONC | 1 | Buy | $340.00 | -9.96% | Initiates Coverage On | 7 months ago |
Pds Biotechnology CorpPDSB | 6 | Strong Buy | $3.00 | +170.27% | Maintains | a year ago |
Oric Pharmaceuticals IncORIC | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Tango Therapeutics IncTNGX | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Arcellx IncACLX | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Summit Therapeutics IncSMMT | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Scholar Rock Holding CorpSRRK | 1 | Buy | $42.00 | +1.23% | Initiates Coverage On | a year ago |
Revolution Medicines IncRVMD | 1 | Buy | $75.00 | -59.89% | Initiates Coverage On | a year ago |
Celcuity IncCELC | 1 | Buy | $110.00 | +68.58% | Initiates Coverage On | a year ago |
Journey Medical CorpDERM | 6 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Bicycle Therapeutics PLCBCYC | 7 | Hold | $14.00 | N/A | Maintains | a year ago |
Rigel Pharmaceuticals IncRIGL | 6 | Hold | $24.00 | N/A | Maintains | 2 years ago |
Geron CorpGERN | 4 | Strong Buy | $3.50 | N/A | Maintains | 2 years ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 4 | Hold | $60.00 | N/A | Downgrades | 2 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Ovid Therapeutics IncOVID | 2 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Viridian Therapeutics IncVRDN | 3 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Hold | $30.00 | N/A | Downgrades | 3 years ago |
Mirati Therapeutics IncMRTX | 5 | Hold | $60.00 | N/A | Downgrades | 3 years ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $36.00 | N/A | Maintains | 3 years ago |
Infinity Pharmaceuticals IncINFI | 1 | Hold | $1.50 | N/A | Downgrades | 4 years ago |
In8bio IncINAB | 3 | Hold | $90.00 | N/A | Downgrades | 4 years ago |
Allogene Therapeutics IncALLO | 2 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Entera Bio LtdENTX | 1 | Strong Buy | $5.00 | N/A | Maintains | 4 years ago |
Vincerx Pharma IncVINC | 2 | Strong Buy | $120.00 | N/A | Maintains | 4 years ago |
Mink Therapeutics IncINKT | 1 | Strong Buy | $10.00 | N/A | Maintains | 5 years ago |
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $6.00 | N/A | Maintains | 5 years ago |
Forte Biosciences IncFBRX | 2 | Hold | $75.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.